Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erika Sironi is active.

Publication


Featured researches published by Erika Sironi.


PLOS ONE | 2011

The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins

Claudia Manzoni; Laura Colombo; Paolo Bigini; Valentina Diana; Alfredo Cagnotto; Massimo Messa; Monica Lupi; Valentina Bonetto; Mauro Pignataro; Cristina Airoldi; Erika Sironi; Alun Williams; Mario Salmona

Accumulation of β-sheet-rich peptide (Aβ) is strongly associated with Alzheimers disease, characterized by reduction in synapse density, structural alterations of dendritic spines, modification of synaptic protein expression, loss of long-term potentiation and neuronal cell death. Aβ species are potent neurotoxins, however the molecular mechanism responsible for Aβ toxicity is still unknown. Numerous mechanisms of toxicity were proposed, although there is no agreement about their relative importance in disease pathogenesis. Here, the toxicity of Aβ 1–40 and Aβ 1–42 monomers, oligomers or fibrils, was evaluated using the N2a cell line. A structure-function relationship between peptide aggregation state and toxic properties was established. Moreover, we demonstrated that Aβ toxic species cross the plasma membrane, accumulate in cells and bind to a variety of internal proteins, especially on the cytoskeleton and in the endoplasmatic reticulum (ER). Based on these data we suggest that numerous proteins act as Aβ receptors in N2a cells, triggering a multi factorial toxicity.


Chemistry-an Asian Journal | 2013

Natural Compounds against Alzheimer’s Disease: Molecular Recognition of Aβ1–42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMR

Cristina Airoldi; Erika Sironi; Catarina Dias; Filipa Marcelo; Alice Martins; Amélia P. Rauter; Francesco Nicotra; Jesús Jiménez-Barbero

Amyloid peptides, Aβ1-40 and Aβ1-42, represent major molecular targets to develop potential drugs and diagnostic tools for Alzheimers Disease (AD). In fact, oligomeric and fibrillar aggregates generated by these peptides are amongst the principal components of amyloid plaques found post mortem in patients suffering from AD. Rosmarinic acid has been demonstrated to be effective in preventing the aggregation of amyloid peptides in vitro and to delay the progression of the disease in animal models. Nevertheless, no information is available about its molecular mechanism of action. Herein, we report the NMR characterization of the interaction of Salvia sclareoides extract and that of its major component, rosmarinic acid, with Aβ1-42 peptide, whose oligomers have been described as the most toxic Aβ species in vivo. Our data shed light on the structural determinants of rosmarinic acid-Aβ1-42 oligomers interaction, thus allowing the elucidation of its mechanism of action. They also provide important information for the rational design of new compounds with higher affinity for Aβ peptides to generate new anti-amyloidogenic molecules and/or molecular tools for the specific targeting of amyloid aggregates in vivo. In addition, we identified methyl caffeate, another natural compound present in different plants and human diet, as a good ligand of Aβ1-42 oligomers, which also shows anti-amyloidogenic activity. Finally, we demonstrated the possibility to exploit STD-NMR and trNOESY experiments to screen extracts from natural sources for the presence of Aβ peptide ligands.


Journal of Biotechnology | 2011

Curcumin derivatives as new ligands of Aβ peptides

Cristina Airoldi; Cristiano Zona; Erika Sironi; Laura Colombo; Massimo Messa; Dario Aurilia; Maria Gregori; Massimo Masserini; Mario Salmona; Francesco Nicotra; Barbara La Ferla

Curcumin derivatives with high chemical stability, improved solubility and carrying a functionalized appendage for the linkage to other entities, have been synthesized in a straightforward manner. All compounds retained Curcumin ability to bind Aβ peptide oligomers without inducing their aggregation. Moreover all Curcumin derivatives were able to stain very efficiently Aβ deposits.


Chemical Communications | 2011

cis-Glyco-fused benzopyran compounds as new amyloid-β peptide ligands

Cristina Airoldi; Francisco Cardona; Erika Sironi; Laura Colombo; Mario Salmona; Artur M. S. Silva; Francesco Nicotra; Barbara La Ferla

A small library of glyco-fused benzopyran compounds has been synthesised. Their interaction features with Aβ peptides have been characterised by using STD-NMR and trNOESY experiments. The conformational analysis of the compounds has also been carried out through molecular mechanics (MM) and molecular dynamics (MD) simulations.


Chemistry: A European Journal | 2014

Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1–42, PrP106–126, and Ataxin-3 Oligomers

Erika Sironi; Laura Colombo; Angela Lompo; Massimo Messa; Marcella Bonanomi; Maria Elena Regonesi; Mario Salmona; Cristina Airoldi

By combining NMR spectroscopy, transmission electron microscopy, and circular dichroism we have identified the structural determinants involved in the interaction of green tea catechins with Aβ1-42, PrP106-126, and ataxin-3 oligomers. The data allow the elucidation of their mechanism of action, showing that the flavan-3-ol unit of catechins is essential for interaction. At the same time, the gallate moiety, when present, seems to increase the affinity for the target proteins. These results provide important information for the rational design of new compounds with anti-amyloidogenic activity and/or molecular tools for the specific targeting of amyloid aggregates in vivo.


Natural Product Reports | 2011

Natural glycoconjugates with antitumor activity

Barbara La Ferla; Cristina Airoldi; Cristiano Zona; Alexandre Orsato; Francisco Cardona; Silvia Merlo; Erika Sironi; Giuseppe D'Orazio; Francesco Nicotra


Organic and Biomolecular Chemistry | 2011

Tetracycline prevents Aβ oligomer toxicity through an atypical supramolecular interaction

Cristina Airoldi; Laura Colombo; Claudia Manzoni; Erika Sironi; Antonino Natalello; Silvia Maria Doglia; Gianluigi Forloni; Fabrizio Tagliavini; Elena Del Favero; Laura Cantù; Francesco Nicotra; Mario Salmona


European Journal of Medicinal Chemistry | 2014

Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide

Cristina Airoldi; Spyridon Mourtas; Francisco Cardona; Cristiano Zona; Erika Sironi; Giuseppe D'Orazio; Eleni Markoutsa; Francesco Nicotra; Sophia G. Antimisiaris; Barbara La Ferla


Pure and Applied Chemistry | 2013

Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer’s disease

Cristina Airoldi; Francisco Cardona; Erika Sironi; Laura Colombo; Mario Salmona; Ilaria Cambianica; F Ornaghi; Giulio Sancini; Francesco Nicotra; Barbara La Ferla


Current Bioactive Compounds | 2011

Aβ Monomers, Oligomers and Fibrils: Structural Features

Cristina Airoldi; Erika Sironi; Barbara La Ferla; Francisco Cardona; Francesco Nicotra

Collaboration


Dive into the Erika Sironi's collaboration.

Top Co-Authors

Avatar

Cristina Airoldi

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar

Francesco Nicotra

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar

Laura Colombo

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar

Mario Salmona

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar

Barbara La Ferla

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cristiano Zona

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar

Silvia Merlo

University of Milano-Bicocca

View shared research outputs
Top Co-Authors

Avatar

Claudia Manzoni

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar

Massimo Messa

Mario Negri Institute for Pharmacological Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge